Original Article
International Journal of Obesity (2007) 31, 1437–1441; doi:10.1038/sj.ijo.0803609; published online 13 March 2007
The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals
E H Young1, N J Wareham1, S Farooqi2, A Hinney3, J Hebebrand3, A Scherag4, S O'Rahilly2, I Barroso5 and M S Sandhu1,6
- 1MRC Epidemiology Unit, Strangeways Research Laboratory, Cambridge, UK
- 2University Department of Clinical Biochemistry, Cambridge Institute for Medical Research, Cambridge, UK
- 3Department of Child & Adolescent Psychiatry, Rheinische Kliniken Essen, University of Duisburg-Essen, Essen, Germany
- 4Institute of Medical Biometry & Epidemiology, Philipps-University of Marburg, Marburg, Germany
- 5Metabolic Disease Group, The Wellcome Trust Sanger Institute, Hinxton, UK
- 6Department of Public Health & Primary Care, Institute of Public Health, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK
Correspondence: Dr EH Young, MRC Epidemiology Unit, Medical Research Council, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN, UK. E-mail: elizabeth.young@mrc-epid.cam.ac.uk
Received 30 October 2006; Revised 20 December 2006; Accepted 22 January 2007; Published online 13 March 2007.
Abstract
Background:
Previous studies have suggested that a variant in the melanocortin-4 receptor (MC4R) gene is important in protecting against common obesity. Larger studies are needed, however, to confirm this relation.
Methods:
We assessed the association between the V103I polymorphism in the MC4R gene and obesity in three UK population based cohort studies, totalling 8304 individuals. We also did a meta-analysis of relevant studies, involving 10 975 cases and 18 588 controls, to place our findings in context.
Finding:
In an analysis of all studies, individuals carrying the isoleucine allele had an 18% (95% confidence interval 4–30%, P=0.015) lower risk of obesity compared with non-carriers. There was no heterogeneity among studies and no apparent publication bias.
Interpretation:
This study confirms that the V103I polymorphism protects against human obesity at a population level. As such it provides proof of principle that specific gene variants may, at least in part, explain susceptibility and resistance to common forms of human obesity. A better understanding of the mechanisms underlying this association will help determine whether changes in MC4R activity have therapeutic potential.
Keywords:
genetics, MC4R, meta-analysis, polymorphism
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
International Journal of Obesity Original Article
International Journal of Obesity Original Article
Association of the MC4R V103I Polymorphism With the Metabolic Syndrome: The KORA Study
Obesity Article Response
International Journal of Obesity Original Article

